Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era
- PMID: 7538236
- DOI: 10.1016/s0090-4295(99)80076-4
Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era
Abstract
Without question, much has been learned about the glycoprotein PSA in recent years. By increasing our understanding of this tumor marker's biochemical and physiologic properties, we will be able to improve its clinical utility. The discovery of the various molecular forms of PSA represents a significant advancement. Knowing the concentration and ratio of these PSA forms will be valuable in deciding which patients require further evaluation with transrectal ultrasound and prostate biopsy and which men can be monitored safely without undergoing further invasive testing. This information will be most valuable in treating the patient with a mildly elevated serum PSA level. Although assays are not yet available to detect specifically hK2, the striking similarities of hK2 to PSA, including selective expression in the prostate, suggest that this marker may also prove useful in prostate cancer management. Indeed, a new era of PSA testing has been entered, and the entire field of prostate cancer will benefit.
Similar articles
-
Prostate-specific antigen (hK3) and human prostatic glandular kallikrein (hK2) in the detection of early stage human prostate cancer.J Lab Clin Med. 1998 Apr;131(4):298-9. doi: 10.1016/s0022-2143(98)90178-0. J Lab Clin Med. 1998. PMID: 9579381 No abstract available.
-
Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate.Crit Rev Clin Lab Sci. 1998 Aug;35(4):275-368. doi: 10.1080/10408369891234219. Crit Rev Clin Lab Sci. 1998. PMID: 9759557 Review.
-
Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity.Urology. 1998 May;51(5):804-9. doi: 10.1016/s0090-4295(98)00107-1. Urology. 1998. PMID: 9610595
-
Structural comparison of prostate-specific antigen and human glandular kallikrein using molecular modeling.Urology. 1995 May;45(5):801-6. doi: 10.1016/S0090-4295(99)80087-9. Urology. 1995. PMID: 7538242
-
Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.J Urol. 1991 May;145(5):907-23. doi: 10.1016/s0022-5347(17)38491-4. J Urol. 1991. PMID: 1707989 Review.
Cited by
-
Thiophilic-interaction chromatography of enzymatically active tissue prostate-specific antigen (T-PSA) and its modulation by zinc ions.J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Jan 15;861(2):227-35. doi: 10.1016/j.jchromb.2007.11.039. Epub 2007 Dec 4. J Chromatogr B Analyt Technol Biomed Life Sci. 2008. PMID: 18083072 Free PMC article.
-
Textural Features of MR Images Correlate with an Increased Risk of Clinically Significant Cancer in Patients with High PSA Levels.J Clin Med. 2023 Apr 12;12(8):2836. doi: 10.3390/jcm12082836. J Clin Med. 2023. PMID: 37109173 Free PMC article.
-
Overexpression of kallikrein gene 10 is a biomarker for predicting poor prognosis in gastric cancer.World J Gastroenterol. 2013 Dec 28;19(48):9425-31. doi: 10.3748/wjg.v19.i48.9425. World J Gastroenterol. 2013. PMID: 24409072 Free PMC article.
-
Screening and Detection of Prostate Cancer-Review of Literature and Current Perspective.Indian J Surg Oncol. 2017 Jun;8(2):160-168. doi: 10.1007/s13193-016-0584-3. Epub 2017 Jan 23. Indian J Surg Oncol. 2017. PMID: 28546712 Free PMC article. Review.
-
Emerging PSA-based tests to improve screening.Urol Clin North Am. 2014 May;41(2):267-76. doi: 10.1016/j.ucl.2014.01.003. Epub 2014 Feb 26. Urol Clin North Am. 2014. PMID: 24725489 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous